COMMUNIQUÉS West-GlobeNewswire

-
Syneos Health to Share Critical Insights for Maximizing Value and Fueling Commercial Success at Biotech Showcase Events
04/01/2019 -
Femasys Announces First 100 Women Treated in Pivotal Clinical Trial with FemBloc® Permanent Contraceptive System
04/01/2019 -
OrthoPediatrics Corp. Announces Direct Sales Agency Expansion in Belgium and the Netherlands
04/01/2019 -
HMS Hires Robert P. Borchert as New Investor Relations Officer
04/01/2019 -
Diffusion Pharmaceuticals Chief Executive Officer David Kalergis to Present at 37th Annual J.P. Morgan Healthcare Conference
04/01/2019 -
La Jolla Pharmaceutical Company to Present at the 37th Annual J.P. Morgan Healthcare Conference
04/01/2019 -
Affimed to Present at the 37th Annual J.P. Morgan Healthcare Conference
04/01/2019 -
Tauriga Sciences Inc. Reveals Several of the Specific & Differentiating Features Integrated into its Cannabis/CBD Infused Chewing Gum Product Line
04/01/2019 -
Ultragenyx Announces Positive Topline Results from First Cohort of Phase 1/2 Clinical Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia
04/01/2019 -
Resonant Inc. to Present at the 21st Annual Needham Growth Conference
04/01/2019 -
BioCryst Appoints Steve Aselage to Board of Directors
04/01/2019 -
Surface Oncology Announces Appointment of F. Stephen Hodi, MD to its Scientific Advisory Board
04/01/2019 -
CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Sickle Cell Disease
04/01/2019 -
Dr. Henry Ji to Participate In Financing Expert Panel at East/West CEO Conference
04/01/2019 -
Mersana Therapeutics Announces Strategic Priorities and Goals for 2019 and Beyond
04/01/2019 -
Nabriva Therapeutics Announces Acceptance of the New Drug Application for Intravenous CONTEPO™ to Treat Complicated Urinary Tract Infections by FDA
04/01/2019 -
Emergent BioSolutions Announces Daniel J. Abdun-Nabi to Retire as CEO; Robert G. Kramer, Sr. to Become President and CEO
04/01/2019 -
OraSure Technologies, Inc. Announces Two Acquisitions and Reaffirms Fourth Quarter 2018 Guidance
04/01/2019 -
Vistin Pharma ASA : Trading update for Energy Trading
04/01/2019
Pages